NANOSTRING TECHNOLOGIES, INC. Financials NanoString Technologies, Inc.
Equities
NSTGQ
US63009R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.29 USD | +1.75% |
|
+45.00% | -61.25% |
| Apr. 22 | Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies | MT |
| Apr. 19 | Motion for Asset Sale Approved for NanoString Technologies, Inc. | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 189.6 | 457.2 | 994.2 | 2,947 | 1,928 | 371.8 |
| Enterprise Value (EV) 1 | 161 | 421.6 | 950.5 | 2,709 | 1,831 | 426.1 |
| P/E ratio | -4.07 x | -5.34 x | -23.6 x | -23.7 x | -16.6 x | -2.32 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.65 x | 4.28 x | 7.92 x | 25.1 x | 13.3 x | 2.92 x |
| EV / Revenue | 1.4 x | 3.95 x | 7.57 x | 23.1 x | 12.6 x | 3.35 x |
| EV / EBITDA | -4.62 x | -6.45 x | -12.2 x | -32.9 x | -17.9 x | -2.95 x |
| EV / FCF | -7.23 x | -18.6 x | -15.4 x | -55 x | -36.7 x | -4.58 x |
| FCF Yield | -13.8% | -5.38% | -6.48% | -1.82% | -2.72% | -21.8% |
| Price to Book | 4.73 x | 12.4 x | 9.7 x | 9.68 x | 10.9 x | 8.13 x |
| Nbr of stocks (in thousands) | 25,383 | 30,831 | 35,738 | 44,065 | 45,651 | 46,647 |
| Reference price 2 | 7.470 | 14.83 | 27.82 | 66.88 | 42.23 | 7.970 |
| Announcement Date | 3/7/18 | 3/11/19 | 3/2/20 | 3/1/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 114.9 | 106.7 | 125.6 | 117.3 | 145.1 | 127.3 |
| EBITDA 1 | -34.84 | -65.32 | -77.78 | -82.31 | -102.4 | -144.4 |
| EBIT 1 | -38.2 | -69.39 | -82.7 | -88.05 | -108.2 | -152.2 |
| Operating Margin | -33.24% | -65.02% | -65.86% | -75.05% | -74.59% | -119.58% |
| Earnings before Tax (EBT) 1 | -43.36 | -77.15 | -40.43 | -109.8 | -115.1 | -159.2 |
| Net income 1 | -43.56 | -77.4 | -40.7 | -110.1 | -115.3 | -159.5 |
| Net margin | -37.91% | -72.52% | -32.41% | -93.83% | -79.44% | -125.37% |
| EPS 2 | -1.836 | -2.776 | -1.177 | -2.817 | -2.544 | -3.438 |
| Free Cash Flow 1 | -22.25 | -22.66 | -61.63 | -49.25 | -49.85 | -93.05 |
| FCF margin | -19.37% | -21.24% | -49.08% | -41.98% | -34.36% | -73.11% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/7/18 | 3/11/19 | 3/2/20 | 3/1/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 33.86 | 37.15 | 42.46 | 31.08 | 32.22 | 29.54 | 34.42 | 35.8 | 44.16 | 48.09 |
| EBITDA 1 | -24.2 | -19.74 | -19.63 | -27.3 | -27.46 | -26.09 | -27.71 | -27.16 | -26.7 | -20.21 |
| EBIT 1 | -25.64 | -29.37 | -27.35 | -37.47 | -37.09 | -34.94 | -42.68 | -40.55 | -42.89 | -36.47 |
| Operating Margin | -75.7% | -79.07% | -64.42% | -120.56% | -115.12% | -118.28% | -123.99% | -113.25% | -97.13% | -75.83% |
| Earnings before Tax (EBT) 1 | -26.94 | -31.32 | -29.18 | -39.42 | -39.06 | -36.63 | -44.12 | -41.16 | -43.46 | -37.46 |
| Net income 1 | -27.02 | -31.26 | -29.26 | -39.5 | -39.24 | -36.69 | -44.11 | -41.24 | -43.67 | -37.41 |
| Net margin | -79.79% | -84.15% | -68.92% | -127.09% | -121.79% | -124.2% | -128.16% | -115.17% | -98.89% | -77.8% |
| EPS 2 | -0.6000 | -0.6900 | -0.6400 | -0.8600 | -0.8500 | -0.7900 | -0.9500 | -0.8800 | -0.9200 | -0.7800 |
| Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/4/21 | 11/9/21 | 3/1/22 | 5/10/22 | 8/4/22 | 11/7/22 | 2/28/23 | 5/3/23 | 8/3/23 | 11/6/23 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 54.3 |
| Net Cash position 1 | 28.6 | 35.6 | 43.8 | 238 | 96.5 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -0.3761 x |
| Free Cash Flow 1 | -22.3 | -22.7 | -61.6 | -49.3 | -49.9 | -93 |
| ROE (net income / shareholders' equity) | -166% | -201% | -57.7% | -53.6% | -47.6% | -143% |
| ROA (Net income/ Total Assets) | -18.1% | -30.5% | -25.4% | -13.7% | -13.2% | -22.8% |
| Assets 1 | 240.1 | 253.7 | 160.3 | 804.1 | 872.1 | 698.5 |
| Book Value Per Share 2 | 1.580 | 1.190 | 2.870 | 6.910 | 3.870 | 0.9800 |
| Cash Flow per Share 2 | 1.030 | 0.7900 | 0.8000 | 9.270 | 2.340 | 2.400 |
| Capex 1 | 4.28 | 4.49 | 7.89 | 7.46 | 6.35 | 14.4 |
| Capex / Sales | 3.73% | 4.2% | 6.28% | 6.36% | 4.38% | 11.29% |
| Announcement Date | 3/7/18 | 3/11/19 | 3/2/20 | 3/1/21 | 3/1/22 | 2/28/23 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -61.25% | 13.95M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- NSTGQ Stock
- Financials NanoString Technologies, Inc.
